Home » NOVAGALI PHARMA COMPLETES EUR26 MILLION FINANCING
NOVAGALI PHARMA COMPLETES EUR26 MILLION FINANCING
Novagali Pharma SA, a privately-held biopharmaceutical company that develops
novel ophthalmic products announced today it has secured EUR26 million in a
new financing round involving participation of new and existing investors. With
this new funding, the total capital raised by Novagali since its inception equals
EUR44 million. AGF Private Equity and Bernard Chauvin joined the group of Novagali
Pharma's investors: 1.2.3. Multinova, Auriga Partners, CDC Entreprises Innovation,
Credit Agricole Private Equity, Edmond de Rothschild Investment Partners, FCJE
managed by CDC Entreprises - FP Gestion and Siparex Ventures.
PR
Newswire UK
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May